SUSPECT PULMONARY FIBROSIS
Pulmonary fibrosis can be a key driver of irreversible lung damage and early mortality.1-6 This website is designed to help you play an important role in patients receiving the care they need without delay.
For pulmonologists
Discover information about the impact of pulmonary fibrosis in patients with interstitial lung diseases (ILDs) and the need for early diagnosis, monitoring, management and supportive care.
For rheumatologists
Learn about fibrotic interstitial lung disease (ILD) in patients with connective tissue diseases (CTDs) and the importance of early screening, diagnosis, monitoring and management.
- Fischer A and Distler J. Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases. Clin Rheumatol. 2019;38(10):2673–2681.
- Mathai SC and Danoff SK. Management of interstitial lung disease associated with connective tissue disease. BMJ. 2016;352:h6819.
- Wallace B, Vummidi D, Khanna D. Management of connective tissue diseases associated interstitial lung disease: a review of the published literature. Curr Opin Rheumatol. 2016;28(3):236–245.
- Spagnolo P, Cordier JF, Cottin V. Connective tissue diseases, multimorbidity and the ageing lung. Eur Respir J. 2016;47(5):1535–1558.
- Vacchi C, Sebastiani M, Cassone G, et al. Therapeutic options for the treatment of interstitial lung disease related to connective tissue diseases. A narrative review. J Clin Med. 2020;9(2):407. doi: 10.3390/jcm9020407.
- Maher TM, Wuyts W. Management of fibrosing interstitial lung diseases. Adv Ther. 2019;36(7):1518–1531.